Perspective Therapeutics, Inc.
NYSE · Healthcare · Pharmaceutical Preparations · Seattle, WA
CATX chart
What traders are saying about $CATX
Latest postsPerspective Therapeutics, Inc. news
- Analysts Are Bullish on Top Healthcare Stocks: Perspective Therapeutics (CATX), Oric Pharmaceuticals (ORIC)
The Globe and Mail ·
- BofA Securities Maintains Perspective Therapeutics(CATX.US) With Hold Rating, Maintains Target Price $5
Moomoo ·
- RBC Capital downgrades Perspective Therapeutics to Sector Perform, sets price target to $4
TradingView ·
- RBC Capital downgrades Perspective Therapeutics stock rating on trial data By Investing.com
Investing.com Nigeria ·
- BTIG reiterates Buy on Perspective Therapeutics stock after data By Investing.com
Investing.com UK ·
- Perspective Therapeutics downgraded to Sector Perform at RBC Capital
TipRanks ·
- BTIG on Perspective Therapeutics Inc (CATX): 'would be buyers on weakness'
StreetInsider ·
- Wedbush Adjusts Price Target on Perspective Therapeutics to $9 From $11, Keeps Outperform Rating
marketscreener.com ·
- CATX Stock Dips As Traders Weigh Deep Losses And Cash Runway
Timothy Sykes ·
- Perspective Therapeutics, Inc. (CATX) Latest Stock News & Headlines
Yahoo Finance ·
- Perspective Therapeutics’ [212Pb]VMT-α-NET shows responses in neuroendocrine tumor trial
The Clinical Trial Vanguard ·
- Isoray. (DE) (CATX) Stock Price | Live Quotes & Charts | AMEX
Timothy Sykes ·
Perspective Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | -$103.1M | -$79.3M | -$46.5M | -$10.8M |
| Diluted EPS | $-1.40 | $-1.23 | $-1.74 | – |
| Total assets (year end) | $267.0M | $341.1M | $97.9M | $58.1M |
| Cash and equivalents (year end) | $30.6M | $61.6M | $9.2M | $21.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Perspective Therapeutics, Inc.
- Ticker
- CATX (NYSE)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Seattle, WA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 728387
- Former names
- IsoRay, Inc., Isoray, Inc., CENTURY PARK PICTURES CORP
Frequently asked questions
What exchange is Perspective Therapeutics, Inc. listed on?
Perspective Therapeutics, Inc. trades on the NYSE under the ticker symbol CATX.
What industry is Perspective Therapeutics, Inc. in?
Perspective Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Perspective Therapeutics, Inc. headquartered?
Perspective Therapeutics, Inc.'s business address on file with the SEC is in Seattle, WA.
When does Perspective Therapeutics, Inc.'s fiscal year end?
Perspective Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Perspective Therapeutics, Inc. report?
Perspective Therapeutics, Inc. reported $5.9M in revenue for calendar year 2018, according to its SEC filings.